首页> 外文期刊>Regenerative Biomaterials >Opportunities and challenges for the development of polymer-based biomaterials and medical devices
【24h】

Opportunities and challenges for the development of polymer-based biomaterials and medical devices

机译:聚合物基生物材料和医疗器械开发的机遇与挑战

获取原文
           

摘要

Biomaterials and medical devices are broadly used in the diagnosis, treatment, repair, replacement or enhancing functions of human tissues or organs. Although the living conditions of human beings have been steadily improved in most parts of the world, the incidence of major human's diseases is still rapidly growing mainly because of the growth and aging of population. The compound annual growth rate of biomaterials and medical devices is projected to maintain around 10% in the next 10 years; and the global market sale of biomaterials and medical devices is estimated to reach $400 billion in 2020. In particular, the annual consumption of polymeric biomaterials is tremendous, more than 8000 kilotons. The compound annual growth rate of polymeric biomaterials and medical devices will be up to 15–30%. As a result, it is critical to address some widespread concerns that are associated with the biosafety of the polymer-based biomaterials and medical devices. Our group has been actively worked in this direction for the past two decades. In this review, some key research results will be highlighted.
机译:生物材料和医疗设备广泛用于人体组织或器官的诊断,治疗,修复,替换或增强功能。尽管世界上大部分地区人类的生活条件已得到稳步改善,但主要由于人口的增长和老龄化,主要人类疾病的发病率仍在迅速增长。未来十年,生物材料和医疗设备的复合年增长率预计将保持在10%左右。预计到2020年,生物材料和医疗器械的全球市场销售额将达到4000亿美元。特别是,聚合物生物材料的年消费量巨大,超过8000吨。聚合物生物材料和医疗设备的复合年增长率将达到15-30%。因此,解决一些与基于聚合物的生物材料和医疗设备的生物安全性有关的广泛关注至关重要。在过去的二十年中,我们小组一直朝这个方向积极工作。在这篇综述中,将重点介绍一些关键研究结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号